Sadava, David <br/><br/>
Silibinin reverses drug resistance in human small-cell lung carcinoma cells.  [electronic resource] 

 -  Cancer letters  Oct 2013 
 - 102-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2013.07.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antioxidants--pharmacology<br/>Caspase 3--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>DNA Fragmentation--drug effects<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Humans<br/>Inhibitor of Apoptosis Proteins--metabolism<br/>Lung Neoplasms--metabolism<br/>Silybin<br/>Silymarin--pharmacology<br/>Small Cell Lung Carcinoma--metabolism<br/>Survivin